Ceftin Oral Tablet 250Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Ceftin: Oral tablet (250mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_17938.JPG
Cefuroxime Axetil 250mg Tab
Aurobindo Pharma USA Inc.
Pill Identification: A 33 
Drug Image file DrugItem_18642.JPG
Cefuroxime Axetil 250mg Tab
Northstar Rx LLC
Pill Identification: A 33 
Drug Image file DrugItem_13703.JPG
Cefuroxime Axetil 250mg Tab
Greenstone Ltd
Pill Identification: A 33 
Drug Image file DrugItem_2579.JPG
Cefuroxime Axetil 250mg Tab
Mylan Institutional LLC formerly UDL Laboratories Inc
Pill Identification: RX 751 
Drug Image file DrugItem_2048.JPG
Cefuroxime Axetil 250mg Tab
Actavis Inc. formerly Watson Pharmaceuticals Inc
Pill Identification: LUPIN  |  302
Drug Image file DrugItem_8654.JPG
Cefuroxime Axetil 250mg Tab
Apotex Corp
Pill Identification: C250  |  APO
Drug Image file DrugItem_11932.JPG
Cefuroxime Axetil 250mg Tab
Apotex Corp
Pill Identification: C250  |  APO
Drug Image file DrugItem_17154.JPG
Cefuroxime Axetil 250mg Tab
Wockhardt USA, LLC
Pill Identification: W 921 
Drug Image file DrugItem_12102.JPG
Ceftin 250mg Tab
PD-RX Pharmaceuticals
Pill Identification: GX ES7 
Drug Image file DrugItem_13428.JPG
Cefuroxime Axetil 250mg Tab
Northstar Rx LLC
Pill Identification: P125  |  250
Drug Image file DrugItem_15043.JPG
Cefuroxime Axetil 250mg Tab
Ascend Laboratories, LLC a Subsidiary of Alkem Laboratories Ltd
Pill Identification: 204 
Drug Image file DrugItem_3952.JPG
Cefuroxime Axetil 250mg Tab
STADA Pharmaceuticals Inc
Pill Identification: GX ES7 
Drug Image file DrugItem_17821.JPG
Cefuroxime Axetil 250mg Tab
Citron Pharma LLC
Pill Identification: A 33 
Drug Image file DrugItem_9250.JPG
Ceftin 250mg Tab
GlaxoSmithKline Group of Companies
Pill Identification: GX ES7,Glaxo  |  387
Drug Image file DrugItem_9252.JPG
Ceftin 250mg Tab
GlaxoSmithKline Group of Companies
Pill Identification: GX ES7,Glaxo  |  387
Drug Image file DrugItem_14516.JPG
Cefuroxime Axetil 250mg Tab
Apotex Corp
Pill Identification: LUPIN  |  302
Drug Image file DrugItem_11619.JPG
Cefuroxime Axetil 250mg Tab
Major Pharmaceuticals Inc
Pill Identification: RX 751 
Drug Image file DrugItem_18159.JPG
Cefuroxime Axetil 250mg Tab
PD-RX Pharmaceuticals Incorporated
Pill Identification: A 33 
Drug Image file DrugItem_12416.JPG
Cefuroxime Axetil 250mg Tab
PD-RX Pharmaceuticals
Pill Identification: RX 751 
Drug Image file DrugItem_12103.JPG
Ceftin 250mg Tab
PD-RX
Pill Identification: GX ES7 
Drug Image file DrugItem_14517.JPG
Cefuroxime Axetil 250mg Tab
Lupin Pharmaceuticals
Pill Identification: LUPIN  |  302
Drug Image file DrugItem_7764.JPG
Cefuroxime Axetil 250mg Tab
Lupin Pharmaceuticals
Pill Identification: LUPIN  |  302
Drug Image file DrugItem_3268.JPG
Cefuroxime Axetil 250mg Tab
Ivax Corporation a Division of Teva USA
Pill Identification: GX ES7 
Drug Image file DrugItem_13702.JPG
Cefuroxime Axetil 250mg Tab
Aurobindo Pharma USA Inc.
Pill Identification: A 33 
Drug Image file DrugItem_3184.JPG
Cefuroxime Axetil 250mg Tab
Ranbaxy Pharmaceuticals Inc
Pill Identification: RX 751 
Drug Image file DrugItem_5799.JPG
Ceftin 250mg Tab
Life Cycle Ventures
Pill Identification: GX ES7 

What is this Medicine?

CEFUROXIME (se fyoor OX eem) is a cephalosporin antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.

In-Depth Information
Select a Medication

Ceftin 250mg Tablet

NDC: 001730387
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Urethritis, Upper Respiratory Tract Infections, Pharyngitis, Otitis Media, Bronchitis, Cervicitis, Tonsillitis, Gonorrhea, Lyme Disease, Skin And Skin Structure Infections, Urinary Tract Infection (UTI), Sinusitis, Erythema Migrans, Lower Respiratory Tract Infections

Sometimes used for but not FDA approved for the following conditions:
Pneumonia, Impetigo

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Ceftin 250mg Tablet
Drug Image file DrugItem_9250.JPG
GlaxoSmithKline Group of Companies
Pill Identification: GX ES7,Glaxo  |  387
Shape: oblong
Color: blue,white
Drug Image file DrugItem_9252.JPG
GlaxoSmithKline Group of Companies
Pill Identification: GX ES7,Glaxo  |  387
Shape: oblong
Color: blue,white

Reported Side Effects for Ceftin 250mg Tablet

Stomach Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Cholestasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Cramps Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Blood Vessels Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Chills Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Lightheadedness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<4.0%*
Severity: MODERATE
Onset: DELAYED
Skin Redness Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Kidney Inflammation Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Vaginal Discharge Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Mouth Sores Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Pancytopenia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Restlessness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Yeast Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Drowsiness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Painful Urination Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Hemolytic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Vaginal Infection Incidence:
<5.4%*
Severity: MODERATE
Onset: DELAYED
Low Prothrombin Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Low White Blood Cells Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Pseudomembranous Colitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Serum Sickness Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Sinus Infection Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
0.2-7.0%*
Severity: MILD
Onset: EARLY
High Bilirubin Level Incidence:
0.2%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
0.5-10.6%*
Severity: MILD
Onset: EARLY
Eosinophilia Incidence:
1.0-7.0%*
Severity: MODERATE
Onset: DELAYED
Diaper Rash Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
3.0-7.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ceftin

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5